Overview

Dexamethasone for COVID-19

Status:
Recruiting

Trial end date:
2021-09-21

Target enrollment:

Participant gender:

Summary

This open label clinical trial is to evaluate two different doses of dexamethasone on the health outcome using World Health Organization ordinal scale at day 28 in hospitalized patients with COVID-19.

Phase:

Phase 4

Details

Lead Sponsor:

University of Oklahoma

Treatments:

Dexamethasone